Industry Updates

NSW NDIS Education - Accessing the NDIS:  Role of GPs and Health Professionals

Central and Eastern Sydney PHN is working with the NDIA to roll out six NDIS education and information sessions for primary health providers over the next three months, these sessions will focus on how to populate the Access Request Form (ARF) and other parts of the access process.

See link Accessing the NDIS: Role of GPs and health professionals, to register early so as not to miss out on this very important learning opportunity. For your information the 2 November 2019 session focuses on Access for people with psychosocial disability.

 

Please forward to your colleagues/contacts/networks as you see appropriate.

If you have any questions, please do not hesitate to communicate with:

Jenny Denford
NDIS Transition Lead
Central and Eastern Sydney PHN
Tower A
Level 5
201 Coward Street
Mascot   NSW   2020
 
Phone:  1300 986 991
Direct:   9304 8613
 
E:  j.denford@cesphn.com.au
W:  www.cesphn.com.au

 

Handy Guide for Providers Prescribing RAP Items to Aged Care Residents

Department of Veterans’ Affairs Provider News has published an article, Handy Guide for Providers Prescribing Rehabilitation Appliance Program (RAP) Items to Aged Care Residents, advising health providers prescribing RAP items for clients in Residential Aged Care Facilities that there is now access to an online Aged Care Eligibility Matrix for reference.


E-Newsletter: Australian Healthcare and Hospitals Assocation

Click here for the latest e-newsletter from AHHA.
 

E-Newsletter: Australian Digital Health Agency

Click here for the latest e-newsletter from the Australian Digital Health Agency.
 

Speaker Series – Real-World Evidence with Aflibercept in Wet Age-Related Macular Degeneration

This review is a summary of an interesting dinner symposium chaired by Dr Jennifer Arnold (Marsden Eye Specialists, Sydney, NSW), focused on real-world evidence about the use of aflibercept in patients with wet age-related macular degeneration.

European experience with aflibercept use was presented by Professor Jean-François Korobelnik (Bordeaux University Hospital, Bordeaux, France) and by Mr Ian Pearce (Royal Liverpool University Hospital, Liverpool, UK).

Attendees at the symposium comprised ophthalmologists and macula specialists from around Australia, and key topics during the meeting included discussion of data from the RAINBOW, PERSEUS and other real-world studies of aflibercept.

Read the review…